PHARMACEUTICALS
<i> Times Staff and Wire Reports</i>
Schein to Acquire Drug Maker: The Florham Park, N.J.-based company said it will acquire Marsam Pharmaceuticals Inc., another drug manufacturer, for about $240 million cash. Under the agreement, Schein Pharmaceutical Inc. said it expects to make a cash tender offer of $21 for each of Marsam’s outstanding common shares beginning Friday through Sept. 1.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
